Clinical Trials Logo

Filter by:
NCT ID: NCT05846100 Recruiting - Cesarean Section Clinical Trials

Conventional Palpation Versus Ultrasound Assisted Spinal Anesthesia in Obstetrics

Start date: November 1, 2022
Phase: N/A
Study type: Interventional

Spinal anesthesia in obese parturients is commonly difficult yet there are no guidelines to direct best practice. The failure leads to suboptimal patient outcomes. Ultrasonography is now considered standard care for central venous access and regional anesthesia and it can be used to visualize the anatomy of the spine for this procedure. Goal of the study Evaluate the benefits of preprocedural ultrasound scanning to facilitate neuraxial anesthesia and improve the first-attempt success rate in obese parturients.

NCT ID: NCT05836272 Recruiting - Sepsis, Severe Clinical Trials

Early Administration of Norepinephrine in Sepsis

EA-NE-TUN
Start date: August 1, 2023
Phase: Phase 4
Study type: Interventional

The management of septic states includes, in addition to the specific treatment (antimicrobials and eradication of the source), a restoration of the hemodynamic disorders and assistance of the failing organs. In general, the restoration of hemodynamic disorders begins first with volume expansion, followed by the use of Noepinephrine (NE) when the target mean arterial pressure (MAP) is not reached after optimizing the intravascular volume. Recently, several studies have supported the interest of early NE on MAP, cardiac output and mortality. It is therefore tempting to restrict fluid administration even in the initial phase of hemodynamic management of severe sepsis by starting NE earlier.

NCT ID: NCT05722782 Recruiting - Renal Colic Clinical Trials

Oral NSAI Versus Acetaminophen or Placebo as a Discharge Treatment of Non Complicated Renal Colics

NAP-RC
Start date: July 1, 2023
Phase: Phase 2
Study type: Interventional

Treatment with NSAI in renal colics has not been well investigated and there is no clear recommendations regarding this subject. The aim of this study is to determine if an oral NSAI treatment is beneficial in patients discharged for the emergency department after the first line treatment of a renal colic investigating the reccurence of pain, the reconsultation rates and the admissions.

NCT ID: NCT05646433 Recruiting - Clinical trials for Gastro Intestinal Bleed

Validation of a New Score for UGI Bleeding in the ED: the Study of the TU-GIB Score

TU-GIBscore
Start date: June 2, 2023
Phase:
Study type: Observational

We have developed a new reliable, easy and reproducible clinical and biological score to select patients presenting to the emergency department with upper GI bleeding and at high risk of developing complications in order to plan an adequate management. This score was compared to the Glasgow-Blatchford score and showed better results in predicting rebleeding, the need for hemostasis therapy and any complications at day 30 including mortality. In a second step and as an objective of this study, it is necessary to perform an external validation of this score in different emergency departments.

NCT ID: NCT05605704 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Olive Leaf Extracts in the Control of Diabet

Dia-Athr
Start date: January 1, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

This study will be carried out in 2 emergency departments (at the exit of the emergency room) and 2 external consultations (endocrinology of the CHU FB Monastir and diabetology consultation, Jemmal hospital). Patients over 18 years of age with: -Diabets

NCT ID: NCT05540600 Recruiting - Atrial Fibrillation Clinical Trials

Left Atrium Reservoir Function Modulation in Patients With Atrial Fibrillation: Digoxin Versus Beta Blocker

Start date: September 12, 2022
Phase: Phase 3
Study type: Interventional

ß blocker and digoxin effect on left atrium reservoir function are unknown. This is a randomized open label study to compare the effect of theses two molecules on left atrium function

NCT ID: NCT05516446 Recruiting - Clinical trials for Coronary Artery Disease (CAD)

Drug Eluting Balloon Angioplasty Versus Everolimus Platinum Chrome Stent

DEBATE
Start date: August 25, 2021
Phase: N/A
Study type: Interventional

Randomized, open-label, single-center, non-inferiority clinical trial to compare late lumen loss (LLL) at 12 months in Tunisian population undergoing coronary percutaneous intervention between Drug Eluting Balloon treated group and Everolimus platinum chrome stent treated group.

NCT ID: NCT05516173 Recruiting - Hypertension Clinical Trials

Role of Depression in Blood Pressure Control. Study

TUN-BP-BLUE
Start date: August 15, 2022
Phase:
Study type: Observational

Our study aims to evaluate the role of depression in blood pressure control in ambulatory hypertensive patients.

NCT ID: NCT05514925 Recruiting - Clinical trials for Proliferative Diabetic Retinopathy

Cryoapplication Versus Anti-VEGF Before Diabetic Vitrectomy

Start date: November 21, 2017
Phase: Phase 4
Study type: Interventional

Pars-plana vitrectomy (PPV) is the cornerstone of surgical treatment for eyes with complicated proliferative diabetic retinopathy. Anti-VEGF intravitreal injection before PPV has shown a good effect on surgical outcomes. However, many patients present with co-morbidities that contraindicate the usage of anti-VEGF in the pre-operative period. Thus, cryoapplication, an old therapeutic tool for proliferative diabetic retinopathy may be a good alternative. The investigators present herein a comparative study between peripheral retinal cryoapplication and anti-VEGF before vitrectomy for complicated proliferative diabetic retinopathy.

NCT ID: NCT05512923 Recruiting - Clinical trials for Patients Hospitalized for More Than 48 Hours

Incidence and Risk Factors of Venous Thrombosis of the Lower Limbs After Hospitalization in Medical Patients at Risk

MTE
Start date: August 15, 2021
Phase:
Study type: Observational

In Tunisia, the available data are limited regarding the incidence of venous thrombosis of the lower limbs (TVMI) post-hospitalization, whether symptomatic or subclinical. The thromboprophylactic strategy will certainly depend on the incidence of this complication and its severity. In this study, we performed a systematic screening for TVMI in a well-characterized cohort of patients discharged after hospitalization >48h for an acute medical condition.